An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants

Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban. NOACs have several benefits over warfarin, including faster time to the achieve effect, rapid onset of action, fewer docume...

Descripción completa

Detalles Bibliográficos
Autores principales: Mujer, Mark Terence P., Rai, Manoj P., Atti, Varunsiri, Dimaandal, Ian Limuel, Chan, Abigail S., Shrotriya, Shiva, Gundabolu, Krishna, Dhakal, Prajwal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097770/
https://www.ncbi.nlm.nih.gov/pubmed/32231703
http://dx.doi.org/10.1155/2020/7636104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097770/
https://www.ncbi.nlm.nih.gov/pubmed/32231703
http://dx.doi.org/10.1155/2020/7636104

Ejemplares similares